Next Article in Journal
Comment on Jun, S.Y.; et al. “Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma” Cancers 2020, 12, 2199
Previous Article in Journal
Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas
Previous Article in Special Issue
Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 12
Issue 10
10.3390/cancers12102981
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Erratum to Cancers 2020, 12(2), 512.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512

by
Mohammad Krayem
1,*,†,
Philippe Aftimos
2,†,
Ahmad Najem
1,
Tim van den Hooven
3,
Adriënne van den Berg
3,
Liesbeth Hovestad-Bijl
3,
Rik de Wijn
3,
Riet Hilhorst
3,
Rob Ruijtenbeek
3,
Malak Sabbah
1,
Joseph Kerger
2,
Ahmad Awada
1,2,
Fabrice Journe
1 and
Ghanem E. Ghanem
1
1
Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium
2
Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium
3
PamGene International BV, 5211HH ‘s-Hertogenbosch, The Netherlands
*
Author to whom correspondence should be addressed.
†
Both authors equally contributed to this manuscript.
Cancers 2020, 12(10), 2981; https://doi.org/10.3390/cancers12102981
Submission received: 24 September 2020 / Accepted: 9 October 2020 / Published: 14 October 2020
(This article belongs to the Special Issue Targeted Therapies for Melanoma)
Versions Notes
The authors would like to make a correction to their published paper [1].
The authors would like to change the title from “Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma” to “Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance”.
We stress that this correction does not change the written portion of the figure legend, interpretation of results, or final conclusion of this manuscript. The authors would like to apologize for any inconvenience caused. The original article has been updated.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Krayem, M.; Aftimos, P.; Najem, A.; van den Hooven, T.; van den Berg, A.; Hovestad-Bijl, L.; de Wijn, R.; Hilhorst, R.; Ruijtenbeek, R.; Sabbah, M.; et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Krayem, M.; Aftimos, P.; Najem, A.; Hooven, T.v.d.; Berg, A.v.d.; Hovestad-Bijl, L.; Wijn, R.d.; Hilhorst, R.; Ruijtenbeek, R.; Sabbah, M.; et al. Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512. Cancers 2020, 12, 2981. https://doi.org/10.3390/cancers12102981

AMA Style

Krayem M, Aftimos P, Najem A, Hooven Tvd, Berg Avd, Hovestad-Bijl L, Wijn Rd, Hilhorst R, Ruijtenbeek R, Sabbah M, et al. Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512. Cancers. 2020; 12(10):2981. https://doi.org/10.3390/cancers12102981

Chicago/Turabian Style

Krayem, Mohammad, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, and et al. 2020. "Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512" Cancers 12, no. 10: 2981. https://doi.org/10.3390/cancers12102981

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop